This finding is consistent with our previous work demonstrating a prominent role for ER status over grade in breast cancer progression in a historical cohort of women with in situ and subsequent invasive lesions [29], and adds to the growing body of literature that suggests low-grade and high-grade ER-positive tumors are more similar to each other than to their ER-negative counterparts [26]. This evidence concerns the gene ESR1 and breast cancer.